Clinical Trial Update: Psilocybin for Treatment-Resistant Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for psilocybin in treatment-resistant depression; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Brain and Cognition Discovery Foundation | Conditions: Treatment Resistant Depression | Phase 2 | Status: COMPLETED